|
1
|
Site-specific PEGylation of native disulfide bonds in therapeutic proteins.
|
Nat Chem Biol
|
2006
|
1.34
|
|
2
|
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.
|
Nat Biotechnol
|
2004
|
1.26
|
|
3
|
Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
|
Bioconjug Chem
|
2007
|
1.16
|
|
4
|
The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors.
|
Blood
|
2003
|
1.09
|
|
5
|
No change to HIV-1 latency with valproate therapy.
|
AIDS
|
2006
|
0.98
|
|
6
|
Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.
|
PLoS Comput Biol
|
2011
|
0.93
|
|
7
|
Optimisation of the degree of sulfation of a polymer based construct to block the entry of HIV-1 into cells.
|
J Drug Target
|
2003
|
0.89
|
|
8
|
Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.
|
Biomaterials
|
2011
|
0.87
|
|
9
|
Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers.
|
J Mol Model
|
2010
|
0.87
|
|
10
|
HIV DNA two long terminal repeat circles: observations and interpretations.
|
AIDS
|
2003
|
0.86
|
|
11
|
From sequence to 3D structure of hyperbranched molecules: application to surface modified PAMAM dendrimers.
|
J Mol Model
|
2011
|
0.84
|
|
12
|
Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis.
|
J Infect Dis
|
2009
|
0.82
|
|
13
|
An amphotericin B-based drug for treating experimental Leishmania major infection.
|
Trans R Soc Trop Med Hyg
|
2010
|
0.78
|
|
14
|
Computational design principles for bioactive dendrimer based constructs as antagonists of the TLR4-MD-2-LPS complex.
|
Biomaterials
|
2011
|
0.76
|
|
15
|
Monitoring HIV disease with new and clinically useful surrogate markers.
|
Curr Opin Infect Dis
|
2003
|
0.76
|